Been thinking about what @macattack said recently:- He mentioned the latest investor presentation did not mention funding by way of "R&D refund and Asset sales" as did the previous Investor presentation on 4/10/2018. I agree that this more than likely means a CR is looming given the last quarterly report showed cash of $667k with a cash outflow of $291K. The last R&D refund back in March 2018 was $225K.
What are others thoughts of the reason why the board has left out funding in the latest Investor presentation.? From my perspective, it is strange that the board have left out this important funding arrangement sentence, which leads me to believe a CR is about to occur. ! Interested to hear other holders thoughts, as i am in two minds moving forward.
4/10/2018
29/01/2019
Capital Raising
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.002(13.3%) |
Mkt cap ! $3.997M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $14.26K | 1.041M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 391000 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 300000 | 1 |
View Market Depth
| Last trade - 15.43pm 15/11/2024 (20 minute delay) ? |
| AAJ (ASX) Chart |
